These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 1689393)
1. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein. Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393 [TBL] [Abstract][Full Text] [Related]
2. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Lambert V; Chassot S; Kay A; Trepo C; Cova L Virology; 1991 Nov; 185(1):446-50. PubMed ID: 1718087 [TBL] [Abstract][Full Text] [Related]
3. Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning. Chassot S; Lambert V; Kay A; Godinot C; Trepo C; Cova L Virology; 1994 Apr; 200(1):72-8. PubMed ID: 7510440 [TBL] [Abstract][Full Text] [Related]
4. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks. Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247 [TBL] [Abstract][Full Text] [Related]
5. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963 [TBL] [Abstract][Full Text] [Related]
6. In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization. Sunyach C; Chassot S; Jamard C; Kay A; Trepo C; Cova L Virology; 1997 Aug; 234(2):291-9. PubMed ID: 9268160 [TBL] [Abstract][Full Text] [Related]
7. Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study. Sridhar G; Valliammai T; Varalakshmi CS; Udayasankar K; Panchanadam M; Ramakrishna J; Gopal KV; Jayaraman K; Thyagarajan SP Trop Anim Health Prod; 1993 Nov; 25(4):229-33. PubMed ID: 8109057 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor. Li JS; Tong SP; Wands JR J Virol; 1996 Sep; 70(9):6029-35. PubMed ID: 8709225 [TBL] [Abstract][Full Text] [Related]
9. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. Tong S; Li J; Wands JR J Virol; 1995 Nov; 69(11):7106-12. PubMed ID: 7474130 [TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. Cheung RC; Robinson WS; Marion PL; Greenberg HB J Virol; 1989 Jun; 63(6):2445-51. PubMed ID: 2470915 [TBL] [Abstract][Full Text] [Related]
11. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS; Kotlarski I; Jilbert AR Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364 [TBL] [Abstract][Full Text] [Related]
12. Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction. Sunyach C; Rollier C; Robaczewska M; Borel C; Barraud L; Kay A; Trépo C; Will H; Cova L J Virol; 1999 Apr; 73(4):2569-75. PubMed ID: 10074101 [TBL] [Abstract][Full Text] [Related]
13. Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Yuasa S; Cheung RC; Pham Q; Robinson WS; Marion PL Virology; 1991 Mar; 181(1):14-21. PubMed ID: 1704654 [TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide elicits antibody reactive with the native duck hepatitis B virus pre-S protein. Wen YM; Xu YY; Zhang W; Liu YZ J Gen Virol; 1990 Oct; 71 ( Pt 10)():2467-9. PubMed ID: 2230741 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a hepatitis B virus endemic in herons. Sprengel R; Kaleta EF; Will H J Virol; 1988 Oct; 62(10):3832-9. PubMed ID: 3418788 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. Pugh JC; Di Q; Mason WS; Simmons H J Virol; 1995 Aug; 69(8):4814-22. PubMed ID: 7609048 [TBL] [Abstract][Full Text] [Related]
18. Immunity in Pekin ducks experimentally and naturally infected with duck hepatitis B virus. Vickery K; Freiman JS; Dixon RJ; Kearney R; Murray S; Cossart YE J Med Virol; 1989 Aug; 28(4):231-6. PubMed ID: 2550583 [TBL] [Abstract][Full Text] [Related]
19. Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection. Thermet A; Robaczewska M; Rollier C; Hantz O; Trepo C; Deleage G; Cova L J Virol; 2004 Feb; 78(4):1945-53. PubMed ID: 14747559 [TBL] [Abstract][Full Text] [Related]
20. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation. Khawaja G; Buronfosse T; Jamard C; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans C; Hartmann D; Cova L Virology; 2012 Mar; 425(1):61-9. PubMed ID: 22284894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]